Laboratory Corp of America Holdings
Open
SectorHealthcare
265.21 0.38
Overview
Share price change
24h
Min
262.85
Max
267.22
Income | 113M 278M |
|---|---|
Sales | 22M 3.5B |
P/E Sector Avg | 23.454 49.052 |
EPS | 4.25 |
Dividend yield | 1.1 |
Profit margin | 7.858 |
Employees | 71,000 |
EBITDA | 142M 561M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +16.42% upside |
Dividend yield Sector Avg | 1.10% 2.36% |
|---|---|
Next Earnings | 23 lip 2026 |
Next Dividend date | 10 wrz 2026 |
Next Ex Dividend date | 27 sie 2026 |
Market Cap | 6.2M 22B |
|---|---|
Previous open | 264.83 |
Previous close | 265.21 |
News Sentiment
By Acuity
50%
50%
162 / 342 Ranking in Healthcare
Laboratory Corp of America Holdings Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Laboratory Corp of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.